Proceedings Sandostatin, State of the Art
Author(s)
Bibliographic Information
Proceedings Sandostatin, State of the Art
(Digestion, v. 54 ; Supplement ; 1)
Karger, 1993
Available at 1 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
"Sponsored by Sandoz Pharma Ltd., Basel, Switzerland"--P. iv
Includes bibliographical references and indexes
Description and Table of Contents
Description
The most current information on octreotide and somatostatin is presented in this volume, by a range of contributors from the fields of chemistry, gynaecology, gastroenterology, endocrinology and surgery.
Table of Contents
- Somatostatin - the early days, R. Guillemin
- from somatostatin to sandostatin - history and chemistry, J. Pless
- from somatostatin to sandostatin - pharmacodynamics and pharmacokinetics, P. Marbach et al
- pharmacodynamic effects of sandostatin in the gastrointestinal tract, K.E. Gyr and R. Meier
- octreotide therapy for variceal hemorrhage, J.P. Cello and M.F. Chan
- somatostatin therapy of acute oesophageal variceal bleeding, R.F. McKee
- treatment of aids-related refractory diarrhoea with octreotide, M. Moroni et al
- perioperative use of octreotide in gastrointestinal surgery, S.J. Mulvihill
- treatment of gastrointestinal fistulas with sandostatin, A. Sitges-Serra et al
- prevention of postoperative complications following pancreatic surgery, M. Buchler and H. Friess
- octreotide in dumping and short bowel syndromes, M.J.G. Farthing
- treatment of pancreatic ascites and external pancreatic fistulas with a long-acting somatostatin analogue (sandostatin), I. Segal et al
- potential indications for octreotide in gastroenterology - summary of workshop, A.K. Burroughs and R. Malagelada
- somatostatin analogue therapy in functioning neuroendocrine gut tumors, H.T. Debas and G. Gittes
- gastroenteropancreatic endocrine tumors - effect of sandostatin on tumor growth, R. Arnold et al
- in vitro detection of somatostatin receptors in human tumors, J.C. Reubi et al
- (111)in-octreotide scintigraphy in oncology, E.P. Krenning et al
- use of radiolabeled somatostatin analogs in the identification and treatment of somatostatin receptor - bearing tumors, R.D. Hurst and I.M. Modlin
- the visualization of gastroenteropancreatic endocrine tumors, S.W.J. Lamberts et al
- preclinical studies on the anticancer activity of the somatostatin analog octreotide (SMS 201-995), G. Weckbecker et al
- proceedings of the discussion - "Tolerability and Safety of Sandostatin", V. Popovic et al
- gallstones during octreotide therapy, R.H. Dowling et al
- looking ahead, J. Ginsburg.
by "Nielsen BookData"